C
Celldex Therapeutics, Inc. (CLDX)
NCM – Real Time Price. Currency in USD
32.00
-0.28 (-0.87%)
At close: May 12, 2026, 4:00 PM EDT
32.00
0.00 (0.00%)
After-hours: May 12, 2026, 4:10 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
32.00
-0.28 (-0.87%)
At close: May 12, 2026, 4:00 PM EDT
32.00
0.00 (0.00%)
After-hours: May 12, 2026, 4:10 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $28.9M significantly exceed its total debt $2.3M, ensuring strong financial flexibility
Total current assets $534.7M exceed Total current liabilities $51.0M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$65.2M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 10.49 | 6.05 | 10 | |
| Quick ratio | 10.49 | 5.63 | 10 | |
| Debt to Equity | 0.00 | 0.30 | 10 | |
| Debt to Assets | 0.00 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 2M | 7M | 7M | 2M | 2M |
| Gross Profit | 957K | 4M | 4M | -2M | -2M |
| Operating Income | -107M | -142M | -195M | -287M | -287M |
| Net Income | -112M | -141M | -158M | -259M | -259M |
| EBITDA | -106M | -139M | -192M | -284M | -284M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 9.95 | -29.96 | 3.5 |
| Next quarter | 9.7 | -11.32 | 3.5 |
| Current year | 70.91 | -15.9 | 5.5 |
| Next year | 212.69 | -0.32 | 5.5 |
| Weighted average score | 4.5 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -21.28 | -20.78 | -32.91 | 3.3 |
| Y/Y | -89.69 | -72.67 | -71.82 | -96.25 | 1.0 |
| 3y average | 38.68 | -33.79 | -21.57 | -27.82 | 3.3 |
| 5y average | 5.89 | -35.72 | -18.44 | -40.28 | 2.0 |
| Weighted average score | 2.4 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |